AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitayan-M Tablet

Prescription Icon
Prescription Required

Marketer

Nirosha Lifesciences

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitayan-M Tablet

Combiflex-D tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, and may lower the risk of cardiovascular events. Combiflex-D may be used alone or with other antidiabetic drugs. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized, considering your health status, blood sugar readings, and other medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Adherence to your doctor's prescribed diet and exercise plan is crucial for diabetes management; lifestyle modifications are paramount. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used concurrently with insulin or sulfonylureas; proper identification and management of low blood sugar are essential. This medication isn't suitable for everyone. Prior to use, inform your physician of any pre-existing heart, liver, kidney, or pancreatic conditions, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before commencing treatment. Potential drug interactions exist; disclose all current medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effects. Your physician will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Sitayan-M Tablet

Managing type 2 diabetes

Major Benefits of Sitayan-M Tablet:

Consume this medication according to your physician's prescribed dosage and regimen. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitayan-M Tablet with a meal.

Common Side effects of Sitayan-M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitayan-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sitayan-M Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Sitayan-M Tablet works:

Sitagliptin and metformin, the components of Sitayan-M Tablet, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitayan-M Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitayan-M Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Sitayan-M tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitayan-M Tablets cautiously, potentially requiring dosage modification under medical supervision. Sitayan-M Tablets are contraindicated in individuals with severe kidney disease. Regular kidney function assessments are recommended during treatment.

LiverLiverUNSAFE

The use of Sitayan-M Tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitayan-M Tablet :

Should you forget a Sitayan-M Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Sitayan-M Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitayan-M Tablet

Sitayan-M Tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Prolonged Sitayan-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Sitayan-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach ache, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitayan-M Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitayan-M tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medicine; keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitayan-M) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If you experience these, discontinue Sitayan-M and seek immediate medical attention.
Sitayan-M Tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitayan-M Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Patients with allergies to Sitayan-M Tablet components or excipients, or those suffering from severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Consuming alcohol with Sitayan-M tablets is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitayan-M) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If you experience these, discontinue Sitayan-M and seek immediate medical attention.
Prolonged Sitayan-M Tablet use can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency can cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitayan-M Tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitayan-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach ache, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitayan-M Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitayan-M Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitayan-M) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates avoiding Sitayan-M in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitayan-M and seek immediate medical attention.
Prolonged Sitayan-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitayan-M Tablet
135